Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × tipifarnib × Clear all

NCT00047216 2015-07-23

Tipifarnib in Treating Patients With Recurrent Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms

NCT00006376 2013-12-04

R115777 in Treating Patients With Advanced Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms